physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

The approval is based on results from the admIRE study, which showed 100% of atrial fibrillation patients achieved acute procedural success.

Tarver takes over the lead role at CDRH after serving as interim director since July.

FDA approval of Optune Lua follows the Phase 3 LUNAR trial, showing significant improvement in median overall survival for metastatic NSCLC patients.

As chief medical officer, Foley is expected to guide the clinical direction of True Digital Surgery and the advancement of its Digital Surgical Exoscope Platform.

The app will work alongside prescription drug treatment Flexilev.

The TensWave is designed to provide user-friendly pain relief, complementing Zynex’s NexWave electrotherapy device.